Page 52 - Read Online

Page 287 Hervas et al. J Transl Genet Genom 2021;5:278-87 https://dx.doi.org/10.20517/jtgg.2021.25

study with korean trios. Psychiatry Investig 2014;11:319-24. DOI PubMed PMC
44. Kim BN, Cummins TD, Kim JW, et al. Val/Val genotype of brain-derived neurotrophic factor (BDNF) Val Met polymorphism is
associated with a better response to OROS-MPH in Korean ADHD children. Int J Neuropsychopharmacol 2011;14:1399-410. DOI
PubMed
45. Manchia M, Fanos V. Targeting aggression in severe mental illness: The predictive role of genetic, epigenetic, and metabolomic
markers. Prog Neuropsychopharmacol Biol Psychiatry 2017;77:32-41. DOI PubMed
46. Park S, Kim JW, Kim BN, Shin MS, Yoo HJ, Cho SC. Catechol-O-methyltransferase Val158-Met polymorphism and a response of
hyperactive-impulsive symptoms to methylphenidate: a replication study from South Korea. J Psychopharmacol 2014;28:671-6. DOI
PubMed
47. Salatino-Oliveira A, Genro JP, Zeni C, et al. Catechol-O-methyltransferase valine158methionine polymorphism moderates
methylphenidate effects on oppositional symptoms in boys with attention-deficit/hyperactivity disorder. Biol Psychiatry 2011;70:216-
21. DOI PubMed
48. McGough JJ, McCracken JT, Loo SK, et al. A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity
disorder. J Am Acad Child Adolesc Psychiatry 2009;48:1155-64. DOI PubMed PMC
49. Kereszturi E, Tarnok Z, Bognar E, et al. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate
response in ADHD children. Am J Med Genet B Neuropsychiatr Genet 2008;147B:1431-5. DOI PubMed
50. Cheon KA, Jun JY, Cho DY. Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a
classroom setting in children with attention-deficit hyperactivity disorder. Int Clin Psychopharmacol 2008;23:291-8. DOI PubMed
51. Bruxel EM, Salatino-Oliveira A, Genro JP, et al. Association of a carboxylesterase 1 polymorphism with appetite reduction in children
and adolescents with attention-deficit/hyperactivity disorder treated with methylphenidate. Pharmacogenomics J 2013;13:476-80.
DOI PubMed
52. Nemoda Z, Angyal N, Tarnok Z, Gadoros J, Sasvari-Szekely M. Carboxylesterase 1 gene polymorphism and methylphenidate
response in ADHD. Neuropharmacology 2009;57:731-3. DOI PubMed
53. Thümmler S, Dor E, David R, et al. Pharmacoresistant severe mental health disorders in children and adolescents: functional
abnormalities of cytochrome P450 2D6. Front Psychiatry 2018;9:2. DOI PubMed PMC